Sens. Susan Collins (L) and Shelley Moore Capito (J. Scott Applewhite/AP Images)
March 3, 2022 07:09 AM ESTUpdated 07:40 AM
FDA+

Two Re­pub­li­can sen­a­tors call on CMS to not re­strict cov­er­age to amy­loid-tar­get­ed Alzheimer's drugs

Zachary Brennan

Senior Editor

Re­pub­li­can Sen­a­tors Su­san Collins of Maine and Shel­ley Moore Capi­to of West Vir­ginia re­cent­ly sent a let­ter to CMS, urg­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Vi­a­tris' In­dia-based man­u­fac­tur­ing site blocked from ship­ping 11 gener­ic drugs to US

A service from the Financial Times